Correction of the platelet link of hemostasis in patients with metabolic syndrome through dietary nutrition
DOI:
https://doi.org/10.32782/2077-6594/2025.1/15Keywords:
metabolic syndrome, carbohydrate-restricted diet, body mass index, basal insulin, platelet hemostasisAbstract
Purpose. To investigate the effect of following a low-carbohydrate diet on platelet link of hemostasis in patients with metabolic syndrome (MS), as well as to evaluate the effect of following this diet on the course of the disease. Materials and methods. 76 patients aged 27 to 64 years with MS were examined. All patients gave written informed consent to participate in the study. A low-carbohydrate diet (restriction of carbohydrates to 250 g per day) was prescribed to 50 patients for 12 weeks in addition to standard antihypertensive therapy (main group). 25 patients (control group) received standard antihypertensive therapy. Systolic and diastolic blood pressure (SBP and DBP) were measured with a cuff of the appropriate size, body mass index (BMI) was calculated using a standard generally accepted formula, fasting glucose levels was determined using glucose oxidase, basal insulin levels in the blood was measured using a radioimmunoassay method, platelet aggregation (PA) with different inducers was examined spectrophotometrically on an aggregometer using aggregation inducers (adenosine-5-diphosphate disodium salt (ADP) and ristocetin). Abovementioned parameters were registered twice (before the start of the study and after 12 weeks). Statistical analysis was performed using the SPSS statistical program (version 22.0, IBM Corp, USA). Results. In patients in the main group (standard antihypertensive therapy and low-carbohydrate diet), after 12 weeks, a statistically significant decrease in the levels of SBP (p=0.001), DBP (p=0.005), basal insulin (p=0.02), improvement in ADP-induced (p=0.01) and ristocetin-induced PA (p=0.01) were registered, while in patients in the control group, only a decrease in the levels of SBP (p=0.002), DBP (0.004), and improvement in ADP-induced PA (p=0.02) were noticed. Conclusions. A carbohydrate-restricted diet is advisable to recommend to patients with metabolic syndrome.
References
Alemany M. The Metabolic Syndrome, a Human Disease. Int J Mol Sci. 2024 Feb 13;25(4):2251. DOI: 10.3390/ijms25042251.
Prado Y, Aravena D, Llancalahuen FM, Aravena C, Eltit F, Echeverría C, et al. Statins and Hemostasis: Therapeutic Potential Based on Clinical Evidence. Adv Exp Med Biol. 2023;1408:25-47. DOI: 10.1007/978-3-031-26163-3_2.
Arnoldussen IAC, Witkamp RF. Effects of Nutrients on Platelet Function: A Modifiable Link between Metabolic Syndrome and Neurodegeneration? Biomolecules. 2021 Oct 4;11(10):1455. DOI: 10.3390/biom11101455.
Doundoulakis I, Farmakis IT, Theodoridis X, Konstantelos A, Christoglou M, Kotzakioulafi E, et al. Effects of dietary interventions on cardiovascular outcomes: a network meta-analysis. Nutr Rev. 2024 May 10;82(6):715-725. DOI: 10.1093/nutrit/nuad080.
Yannakoulia M, Scarmeas N. Diets. N Engl J Med. 2024 Jun 13;390(22):2098-2106. DOI: 10.1056/NEJMra2211889.
Ahuja KD, Adams MJ, Robertson IK, Ball MJ. Acute effect of a high-carbohydrate low-fat meal on platelet aggregation. Platelets. 2009 Dec;20(8):606-9. DOI:10.3109/09537100903267517.
Juhász AE, Stubnya MP, Teutsch B, Gede N, Hegyi P, Nyirády P, et al. Ranking the dietary interventions by their effectiveness in the management of polycystic ovary syndrome: a systematic review and network meta-analysis. Reprod Health. 2024 Feb 22;21(1):28. DOI: 10.1186/s12978-024-01758-5.
Ludwig DS, Apovian CM, Aronne LJ, Astrup A, Cantley LC, Ebbeling CB, et al. Competing paradigms of obesity pathogenesis: energy balance versus carbohydrate-insulin models. Eur J Clin Nutr. 2022 Sep;76(9):1209-1221. DOI: 10.1038/s41430-022-01179-2.
Cosemans JM, Iserbyt BF, Deckmyn H, Heemskerk JW. Multiple ways to switch platelet integrins on and off. J Thromb Haemost. 2008 Aug;6(8):1253-61. DOI: 10.1111/j.1538-7836.2008.03041.x.
